Evaluation of Disease Activity in Patients with Rheumatoid Arthritis Treated with Tofacitinib by RAPID3: Post Hoc Analyses from Two Phase 3 Trials
Clin Rheumatol 2018 Aug; 37(8):2043–53
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Clin Rheumatol 2018 Aug; 37(8):2043–53
Arthritis Res Ther 2018; 20(1):57 doi: 10.1186/s13075-018-1541-z
Int J Rheum Dis 2018; 21(2):402–14
Please click the links below to go to the CSF review of each paper.
J Rheumatol 2018 Apr; 45(4):456-464
J Rheumatol 2018 Feb; 45(2):177-87
Nat Rev Drug Discov 2017;16:843–62 DOI: 10.1038/nrd.2017.201
Arthritis Rheumatol 2017;69(10):1960–68
N Engl J Med 2017; 377:1537-50. DOI: 10.1056/NEJMoa1615975
N Engl J Med 2017;377:1525–36.